company background image
688366 logo

Shanghai Haohai Biological Technology SHSE:688366 Stock Report

Last Price

CN¥62.29

Market Cap

CN¥12.9b

7D

0.2%

1Y

-15.5%

Updated

26 Dec, 2024

Data

Company Financials +

Shanghai Haohai Biological Technology Co., Ltd.

SHSE:688366 Stock Report

Market Cap: CN¥12.9b

688366 Stock Overview

Shanghai Haohai Biological Technology Co., Ltd. More details

688366 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance5/6
Financial Health5/6
Dividends4/6

Rewards

Trading at 78.9% below our estimate of its fair value

Earnings are forecast to grow 16.82% per year

Earnings grew by 24.5% over the past year

Trading at good value compared to peers and industry

Risk Analysis

Unstable dividend track record


My Notes

Capture your thoughts, links and company narrative

Shanghai Haohai Biological Technology Co., Ltd. Competitors

Sunshine Guojian Pharmaceutical (Shanghai)

SHSE:688336

CN¥13.3b

Changchun BCHT Biotechnology

SHSE:688276

CN¥10.7b

Anhui Anke Biotechnology (Group)

SZSE:300009

CN¥14.8b

Pacific Shuanglin Bio-pharmacy

SZSE:000403

CN¥15.8b

Price History & Performance

Summary of share price highs, lows and changes for Shanghai Haohai Biological Technology
Historical stock prices
Current Share PriceHK$62.29
52 Week HighHK$89.27
52 Week LowHK$55.54
Beta0.77
1 Month Change-1.94%
3 Month Change-7.03%
1 Year Change-15.55%
3 Year Change-30.78%
5 Year Change-4.15%
Change since IPO-33.28%

Recent News & Updates

Recent updates

Shareholder Returns

688366CN BiotechsCN Market
7D0.2%-1.9%-1.0%
1Y-15.5%-19.6%10.8%

Return vs Industry: 688366 exceeded the CN Biotechs industry which returned -19.6% over the past year.

Return vs Market: 688366 underperformed the CN Market which returned 10.8% over the past year.

Price Volatility

Is 688366's price volatile compared to industry and market?
688366 volatility
688366 Average Weekly Movement8.5%
Biotechs Industry Average Movement8.8%
Market Average Movement8.8%
10% most volatile stocks in CN Market13.0%
10% least volatile stocks in CN Market5.8%

Stable Share Price: 688366 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 688366's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20072,179Jianying Wuwww.3healthcare.com

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in China, Europe, the United States, and internationally. The company offers ophthalmology products consisting intraocular lens, medical sodium hyaluronate gel, and lubricant eye drop.

Shanghai Haohai Biological Technology Co., Ltd. Fundamentals Summary

How do Shanghai Haohai Biological Technology's earnings and revenue compare to its market cap?
688366 fundamental statistics
Market capCN¥12.91b
Earnings (TTM)CN¥430.21m
Revenue (TTM)CN¥2.75b

13.6x

P/E Ratio

2.1x

P/S Ratio

Is 688366 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688366 income statement (TTM)
RevenueCN¥2.75b
Cost of RevenueCN¥848.86m
Gross ProfitCN¥1.90b
Other ExpensesCN¥1.47b
EarningsCN¥430.21m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.87
Gross Margin69.10%
Net Profit Margin15.66%
Debt/Equity Ratio7.0%

How did 688366 perform over the long term?

See historical performance and comparison

Dividends

3.2%

Current Dividend Yield

85%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 16:38
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shanghai Haohai Biological Technology Co., Ltd. is covered by 17 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jingwei QiChina Merchants Securities Co. Ltd.
Xiaofang XuCitic Securities Co., Ltd.
Eva ZhaoCitigroup Inc